Tag: Pharmaceuticals
Business & Industry
UCB Acquires Candid Therapeutics in a $2 Billion-Plus Deal to Strengthen Immunology Pipeline
Belgian pharmaceutical company UCB is making a substantial move to expand its immunology pipeline, entering into a multi-billion dollar agreement to acquire Candid Therapeutics...
Business & Industry
Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal
Teva Pharmaceuticals has entered into a definitive agreement to acquire Emalex Biosciences, strengthening its neuroscience pipeline through the addition of ecopipam, a late-stage investigational...
Business & Industry
Lilly Acquires CrossBridge to Expand Next-Gen ADC Pipeline
Eli Lilly and Company has entered into an agreement to acquire all outstanding shares of CrossBridge Bio in a transaction valued at up to...
Business & Industry
Regeneron Telix Radiopharma Deal Targets Cancer Therapies
Regeneron Pharmaceuticals has entered into a strategic agreement with Telix Pharmaceuticals to jointly develop next-generation oncology treatments, in a deal valued at up to...
Business & Industry
Drug Manufacturing Deals Shift to Europe Despite Tariffs
Biopharma companies are continuing to redirect production strategies toward Europe, even as U.S. policymakers attempt to strengthen domestic output through tariffs and onshoring measures....
Business & Industry
Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition
Neurocrine Biosciences is close to securing a more than $2.5bn acquisition of Soleno Therapeutics, the developer of a treatment for a rare genetic form...
Business & Industry
Biogen to Acquire Apellis for $5.6 Billion in Major Deal
Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, in a move that significantly expands its presence in immunology and rare...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read